|
January 13, 2021
|
Progenity Provides Financial Guidance for Full-year 2021
|
|
January 5, 2021
|
Progenity to Present at the 2021 ICR Conference
|
|
December 17, 2020
|
Progenity Expands Availability of COVID-19 PCR Testing Services Across United States
|
|
December 8, 2020
|
Progenity Announces Closing of the Convertible Senior Notes Offering and Partial Exercise of the Initial Purchaser’s Option to Purchase Additional Notes
|
|
December 8, 2020
|
Progenity Announces Closing of Public Offering of Common Stock
|
|
December 2, 2020
|
Progenity, Inc. Prices $75.0 Million Convertible Senior Notes Offering
|
|
December 2, 2020
|
Progenity Announces Pricing of Public Offering of Common Stock
|
|
November 30, 2020
|
Progenity Announces Proposed Convertible Senior Notes Offering
|
|
November 30, 2020
|
Progenity Announces Proposed Public Offering of Common Stock
|
|
November 20, 2020
|
New Test for Triaging Preeclampsia Passes Key Development Milestone: Progenity Releases Prospective Clinical Verification Data for its Preecludia™ Test
|